FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a method for reducing the blood uric acid concentration in a mammal patient, or increasing the uric acid discharge in a mammal patient involving administering 2-(3-(2,6-dimethylbenzyloxy)-4-methylphenyl)acetic acid or a pharmaceutically acceptable salt thereof in the effective amount into the patient. Besides, the declared invention is used in a method of treating or preventing a number of conditions, including uratic arthritis, hyperuricemia, the uric acid levels exceeding those normally diagnosed as hyperuricemia, renal dysfunction, renal calculi, cardiovascular disorder, risk of cardiovascular disorder, tumour lysis syndrome and cognitive impairment.
EFFECT: declared compounds may be used for preparing the pharmaceutical composition.
11 cl, 6 dwg, 13 tbl, 28 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501554C2 |
| TETRAZOLE COMPOUNDS FOR REDUCING CONCENTRATION OF URIC ACID | 2009 |
|
RU2522458C2 |
| COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | 2006 |
|
RU2420276C2 |
| COMPOUND FOR TREATING METABOLIC DISORDERS | 2008 |
|
RU2521284C2 |
| COMPOUNDS FOR TREATING METABOLIC DISEASES | 2008 |
|
RU2502723C2 |
| COMPOUNDS FOR TREATMENT OF METABOLIC DISEASES | 2002 |
|
RU2341513C2 |
| TYPE 1 DIACYLGLYCEROL O-ACYLTRANSFERASE ENZYME INHIBITORS | 2008 |
|
RU2497816C2 |
| COMPOUNDS FOR METABOLIC DISORDER TREATMENT | 2004 |
|
RU2358722C2 |
| THIOHYDANTOIN DERIVATIVES USEFUL AS ANDROGEN RECEPTOR ANTAGONISTS | 2012 |
|
RU2598854C2 |
| PYRIMIDINES AND THEIR OPTIONS, AND THEIR APPLICATION | 2017 |
|
RU2760733C2 |
